Aqupharm 1 (9 mg/ml) Solution for Injection/Infusion

Država: Velika Britanija

Jezik: angleščina

Source: VMD (Veterinary Medicines Directorate)

Kupite ga zdaj

Lastnosti izdelka Lastnosti izdelka (SPC)
11-08-2022

Aktivna sestavina:

Sodium Chloride

Dostopno od:

Animalcare Ltd

Koda artikla:

QB05BB01

INN (mednarodno ime):

Sodium Chloride

Farmacevtska oblika:

Solution for infusion

Tip zastaranja:

POM-V - Prescription Only Medicine – Veterinarian

Terapevtska skupina:

Cats, Cattle, Dogs, Goats, Horses, Pigs, Rabbits, Sheep

Terapevtsko območje:

Replacement Agent

Status dovoljenje:

Authorized

Datum dovoljenje:

2016-09-22

Lastnosti izdelka

                                Revised: August 2022
AN: 01024/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Aqupharm 1 (9 mg/ml) solution for injection/infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Sodium Chloride
9 mg
The solution provides
Sodium: 150 mmol/litre
Chloride: 150 mmol/litre
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection/infusion.
Clear, colourless particle free solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Correction of water: sodium imbalances.
Treatment of metabolic alkalosis.
Rehydration in disease conditions which result in excessive loss of
water and sodium
chloride, and during and after surgery.
Vehicle solution for the administration of other compatible drugs.
4.3
CONTRAINDICATIONS
Do not use in cases of:
-
sodium and water retention (due to cardiac, hepatic or renal failure,
or
enteropathy)
-
hypernatraemia
-
hyperchloraemia
-
hyperhydration.
Revised: August 2022
AN: 01024/2022
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Maintain aseptic precautions.
Use with caution in animals with cardiac or renal impairment as sodium
overload may
occur.
It
should
be
noted
that
sodium
excretion
may
be
impaired
post-
surgery/trauma.
Use with caution in animals with hypokalaemia.
Serum electrolyte levels, water and acid-base balance and the clinical
condition of
the animal should be closely monitored during the treatment in order
to prevent
overdose, particularly in cases of renal or metabolic changes.
A risk of thrombosis with intravenous infusion should be considered.
This product should not be used for longer than is necessary to
correct and sustain
circulating volume. Inappropriate/excessive use may worsen or create a
metabolic
acidosis.
This product does not contain an antim
                                
                                Preberite celoten dokument